Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CLOBETASOL | 0.05% | CREAM | Actual shortage | 2024-01-11 | 2024-03-28 | 215704 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Actual shortage | 2017-08-17 | 2017-10-11 | 19683 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Actual shortage | 2017-08-17 | 2017-10-11 | 19688 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109623 |
TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2020-07-30 | 2020-08-21 | 121503 |
TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2021-08-13 | 2021-10-07 | 144108 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-08-18 | 2022-09-08 | 167191 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-12-08 | 2023-01-26 | 177520 |
TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183364 |
TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-02-16 | 2023-10-04 | 184946 |
TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195888 |
TEVA-CLONIDINE | 0.025MG | TABLET | Actual shortage | 2023-10-05 | 2023-10-05 | 206416 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86599 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124968 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2020-12-17 | 126912 |
TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2020-10-22 | 2020-10-30 | 126915 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2021-04-21 | 126942 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-05-13 | 136317 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-04-29 | 136332 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-02 | 2022-01-20 | 145124 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |